2.2840
+0.1440
+(6.73%)
At close: January 10 at 7:59:09 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-142,655.0000
-202,744.0000
-245,343.0000
76,901.0000
137,738.0000
Investing Cash Flow
55,912.0000
-20,585.0000
-29,054.0000
-93,117.0000
-19,340.0000
Financing Cash Flow
72,216.0000
63,081.0000
215,116.0000
154,504.0000
21,740.0000
End Cash Position
156,726.0000
126,080.0000
286,532.0000
346,642.0000
204,435.0000
Capital Expenditure
-26,004.0000
-14,312.0000
-29,322.0000
-93,171.0000
-19,471.0000
Issuance of Capital Stock
--
--
189,837.0000
166,823.0000
290.0000
Issuance of Debt
--
81,111.0000
39,331.0000
859.0000
50,266.0000
Repayment of Debt
-8,138.0000
-5,224.0000
-4,841.0000
-4,761.0000
-24,106.0000
Repurchase of Capital Stock
--
-240.0000
--
--
--
Free Cash Flow
-168,659.0000
-217,056.0000
-274,665.0000
-16,270.0000
118,267.0000
12/31/2020 - 7/6/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALNFL.PA NFL Biosciences SA
1.8700
+1.63%
2H51.F Ocugen, Inc.
0.7720
-7.82%
PI3.F Gubra A/S
86.60
-3.56%
OSE.PA OSE Immunotherapeutics SA
6.75
-1.46%
FYB.F Formycon AG
62.50
+1.63%
0QF.F Moderna, Inc.
41.08
-4.00%
ABVX.PA ABIVAX Société Anonyme
6.47
+2.21%
FYB.DE Formycon AG
62.70
+1.46%
GNFT Genfit S.A.
3.6000
0.00%
NVV1.F Novavax, Inc.
8.89
-6.92%